Recent Matters

  • Represented public companies in various domestic and cross-border transactions, including the recent $1.4 billion acquisition of a world-class CPU and technology company.
  • Represented target public company in public/public all stock tax-free reorganization.
  • Represented public company in its acquisition of a leader in long-term post-acute care software, for $750 million.
  • Represented private target in its acquisition by public company in a tax-free reorganization valued at $500 million.
  • Represented public target in a tender offer valued at $1.8 billion.
  • Represented private target in its $550 million sale to public company. 
  • Represented private target in its $300 million acquisition by public company.
  • Represented a leading provider of supply chain optimization software solutions in its acquisition by private equity firm.
  • Represented a developer of cancer-focused immunotherapy solutions in its $125 million acquisition by public company.
  • Represented a construction and engineering software solutions provider in its acquisition by public company.
  • Represented limited partners on rollover of their equity in connection with the sale of major league baseball franchise. 
  • Represented owner and operator of publicly-held restaurant chain in its $1.1 billion going private transaction.
  • Represented a life sciences research tools company in its $315 million acquisition by public company.